Skip to main content
NVDA-0.82%AAPL+0.91%GOOGL-2.28%MSFT-0.15%AMZN+0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.43%TSLA-1.41%SKHY+7.05%MU-2.00%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.20%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.52%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.57%AUDJPY-1.53%USDJPY-1.32%EURJPY-1.29%GBPJPY-1.24%CADJPY-1.17%NZDCAD-1.04%GBPNZD+0.95%EURNZD+0.93%NZDUSD-0.90%USDNOK+0.70%AUDNZD+0.69%NZDCHF-0.66%USDZAR+0.58%EURNOK+0.54%USDSEK+0.49%CHFNOK+0.49%EURZAR+0.44%GBPZAR+0.43%GBPTRY+0.41%AUDCAD-0.38%CADCHF+0.38%EURSEK+0.34%GBPHKD+0.32%GBPCHF+0.31%USDTHB+0.30%USDPLN+0.29%GBPMXN-0.28%CHFSEK+0.28%AUDNOK+0.28%NOKJPY-0.28%GBPAUD+0.27%EURCHF+0.27%AUDDKK-0.27%USDCHF+0.26%SGDJPY+0.26%AUDSGD-0.25%EURAUD+0.24%USDMXN+0.23%AUDUSD-0.22%EURHKD-0.16%USDSGD+0.16%USDILS+0.16%USDDKK+0.15%EURPLN+0.14%USDCAD-0.13%EURCAD-0.13%PLNJPY+0.12%USDTRY+0.11%EURCNH-0.11%GBPCAD-0.09%GBPUSD+0.07%EURCZK-0.07%CHFSGD-0.05%NZDMXN+0.04%AUDCHF+0.04%USDCOP-0.04%EURGBP-0.03%USDCNH+0.02%EURUSD+0.02%EURSGD+0.01%USDHKD+0.01%NZDSGD-0.01%EURDKK0.00%GBPSGD0.00%HG1-4.14%XPTUSD-3.57%COFFEE-2.51%XAGUSD-2.50%GAGUSD-2.50%SUGAR+2.02%USOIL+1.91%UKOIL+1.87%COCOA-1.11%COTTON+0.84%C1+0.76%S1+0.75%BTCUSD-0.64%ETHUSD-0.36%USDTUSD-0.04%XRPUSD-1.35%SOLUSD-0.47%TRXUSDT+0.45%ZECUSDT-2.14%DOGEUSD-1.16%XMRUSDT-1.11%LINKUSD+0.14%XLMUSD-0.97%BCHUSDT-2.64%LTCUSD-1.86%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.07%SUIUSD-1.42%TAOUSDT-1.32%AAVEUSD-2.27%DOTUSDT-2.36%ICPUSDT-1.04%ONDOUSDT-2.01%WLDUSDT-1.71%ATOMUSDT-3.30%ARBUSDT-0.98%JUPUSDT-2.53%INJUSDT-2.31%STXUSDT-2.34%FETUSDT-2.68%TIAUSDT-0.34%PYTHUSDT-0.46%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-3.07%OPUSDT-0.99%POLUSDT-5.30%IOTAUSDT-2.98%AXSUSDT-1.82%FARTCOINUSDT-2.90%EOSUSDT-0.06%DYDXUSDT+0.65%ORDIUSDT-0.28%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.82%AAPL+0.91%GOOGL-2.28%MSFT-0.15%AMZN+0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.43%TSLA-1.41%SKHY+7.05%MU-2.00%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.20%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.52%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.57%AUDJPY-1.53%USDJPY-1.32%EURJPY-1.29%GBPJPY-1.24%CADJPY-1.17%NZDCAD-1.04%GBPNZD+0.95%EURNZD+0.93%NZDUSD-0.90%USDNOK+0.70%AUDNZD+0.69%NZDCHF-0.66%USDZAR+0.58%EURNOK+0.54%USDSEK+0.49%CHFNOK+0.49%EURZAR+0.44%GBPZAR+0.43%GBPTRY+0.41%AUDCAD-0.38%CADCHF+0.38%EURSEK+0.34%GBPHKD+0.32%GBPCHF+0.31%USDTHB+0.30%USDPLN+0.29%GBPMXN-0.28%CHFSEK+0.28%AUDNOK+0.28%NOKJPY-0.28%GBPAUD+0.27%EURCHF+0.27%AUDDKK-0.27%USDCHF+0.26%SGDJPY+0.26%AUDSGD-0.25%EURAUD+0.24%USDMXN+0.23%AUDUSD-0.22%EURHKD-0.16%USDSGD+0.16%USDILS+0.16%USDDKK+0.15%EURPLN+0.14%USDCAD-0.13%EURCAD-0.13%PLNJPY+0.12%USDTRY+0.11%EURCNH-0.11%GBPCAD-0.09%GBPUSD+0.07%EURCZK-0.07%CHFSGD-0.05%NZDMXN+0.04%AUDCHF+0.04%USDCOP-0.04%EURGBP-0.03%USDCNH+0.02%EURUSD+0.02%EURSGD+0.01%USDHKD+0.01%NZDSGD-0.01%EURDKK0.00%GBPSGD0.00%HG1-4.14%XPTUSD-3.57%COFFEE-2.51%XAGUSD-2.50%GAGUSD-2.50%SUGAR+2.02%USOIL+1.91%UKOIL+1.87%COCOA-1.11%COTTON+0.84%C1+0.76%S1+0.75%BTCUSD-0.64%ETHUSD-0.36%USDTUSD-0.04%XRPUSD-1.35%SOLUSD-0.47%TRXUSDT+0.45%ZECUSDT-2.14%DOGEUSD-1.16%XMRUSDT-1.11%LINKUSD+0.14%XLMUSD-0.97%BCHUSDT-2.64%LTCUSD-1.86%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.07%SUIUSD-1.42%TAOUSDT-1.32%AAVEUSD-2.27%DOTUSDT-2.36%ICPUSDT-1.04%ONDOUSDT-2.01%WLDUSDT-1.71%ATOMUSDT-3.30%ARBUSDT-0.98%JUPUSDT-2.53%INJUSDT-2.31%STXUSDT-2.34%FETUSDT-2.68%TIAUSDT-0.34%PYTHUSDT-0.46%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-3.07%OPUSDT-0.99%POLUSDT-5.30%IOTAUSDT-2.98%AXSUSDT-1.82%FARTCOINUSDT-2.90%EOSUSDT-0.06%DYDXUSDT+0.65%ORDIUSDT-0.28%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
HA

Haemonetics Corporation (HAE)

NYSE • Healthcare

$103.16
+$0.31 (+0.3%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$102.15
Day Range$100.57 - $103.18
Avg. Volume (3M)753K
Market Cap$4.6B
P/E Ratio50.1
52 Week Range
$47.32$109.57
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$339.3M100%
Gross Profitminus cost of goods$202.8M60%
Operating Incomeminus R&D and overhead$57.4M17%
Net Incomeminus taxes and the rest$33M10%

In plain terms: out of every $100 in revenue, Haemonetics Corporation keeps $10 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.3B
Net Income (TTM)
$96.2M
EPS (TTM)
$2.06
ROA (TTM)
4.07%
Current Ratio
3.08
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+3.1%Q1 2026$1.31
+0.8%Q2 2026$1.29
+5.6%Q3 2026$1.14
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +5.6%

Haemonetics Corporation beat expectations on both the top and bottom line in the first fiscal quarter of 2027, reporting results on Aug. 6, as adjusted EPS of $1.14 topped the $1.08 estimate by 5.6% and revenue of about $339.4 million exceeded the $327.9 million consensus by 3.5%. Revenue rose 5.6% from about $321.4 million a year ago, with gross margin near 60% and operating margin near 17% as operating income came in at about $57.5 million. Net income slipped 3.0% to about $33.0 million, and operating cash flow was about $52.3 million. Consensus for the next period calls for adjusted EPS of $1.30 on revenue of $342.6 million.

View full earnings history

About Haemonetics Corporation

Haemonetics Corporation trades on the NYSE under HAE and makes blood and plasma collection, transfusion-management, and surgical blood-management equipment and software for healthcare providers. In FY2026, the company generated $1.3 billion in revenue. Founded in 1971, Haemonetics operates from Boston, Massachusetts and has been public since 1991.

Name
Haemonetics Corporation
CEO
Christopher A. Simon
Website
www.haemonetics.com
Industry
Healthcare
Year Founded
1971
Employees
3,009

Today's Snapshot

AI-generated

HAE ended yesterday a little higher at 103.16.

Trading Volume

Above 10d avg 604.0K

612.2K

vs S&P 500 Today

Outperforming Market

+0.79%

Updated: September 10, 2026 at 12:07 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
HAE shows a strong-buy technical posture at 103.16, supported by a clear uptrend and price well above most moving averages, including the long-term averages. ADX is strong, indicating trending behavior, and momentum readings are constructive with RSI in favorable territory and a positive MACD level, while ATR points to moderate volatility. On the other hand, OBV shows recent selling, a volume divergence that tempers the strength signal, and the pivot sits near current price. Technical takeaway: Strong Buy.
All signals
  • EMA (5 indicators)$74.68 - $103.01
    Buy
  • RSI (14)65.66
    Neutral
  • Stochastic %K (14, 3, 3)23.73
    Neutral
  • MACD Level (12, 26)4.22
    Neutral

Peers & Related Assets

CONConcentra Group Holdings Parent, Inc.
$34.18+0.9%
ITGRInteger Holdings Corporation
$125.86-0.3%
CPRXCatalyst Pharmaceuticals, Inc.
$31.490.0%
WRBYWarby Parker Inc.
$24.57-0.8%
BEAMBeam Therapeutics Inc.
$25.17-6.2%
XRAYDENTSPLY SIRONA Inc.
$10.72-2.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.